Primary samples repository
Vivia Biotech has access to primary samples from patients diagnosed with hematologic malignancies and solid tumors, through extensive collaboration with national and international hospitals, health centers and biobanks.
Vivia performs feasibility studies to accurately foresee the collection timelines, and puts its own experience, together with our collaborators’s clinical expertise at our customers’ disposal to help you improve your research lines and results.
Vivia’s standard procedures guarantees the suitability and highest quality of samples with a variety of features for our customer’s research. All samples and clinical data from patients who meet the predefined inclusion and exclusion criteria are collected in accordance with GCP guidelines and applicable laws, within the approval framework of the competent Ethics Committee and after patient’s declared consent.
> 0
> 0
> 0
  • Bone marrow
  • Peripheral blood
  • Solid tumors
  • Other biofluids and tissues
  • Fresh samples
  • Cryopreserved samples
  • Acute and Chronic Leukemias
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Lymphomas
  • Solid Tumors (Ovary, Cervix, Gastric, Lung, Carcinomas, etc.)
  • Spain
  • Portugal
  • Italy
  • United Kingdom
  • Greece
  • Poland
  • Czech Republic
  • Bulgaria
  • Romania
  • Serbia
  • Croatia